Pharmaceutical Accountability Foundation

Recent News

PAF’s court case against AbbVie in the media

The Pharmaceutical Accountability Foundation recently launched a court case against pharma-giant AbbVie for excessive pricing of blockbuster drug Humira (adalimumab). We received media attention from...

AbbVie overcharged the Dutch health care system by as much as €1.2 billion for Humira

AMSTERDAM, THE NETHERLANDS: The Pharmaceutical Accountability Foundation (PAF) today brought a lawsuit against pharmaceutical company AbbVie for unfair, excessive pricing practices on its blockbuster medicine...

NEW Policy brief – Time to Legislate: Realising access to medicines through States’ obligation to protect the human right to health

The Pharmaceutical Accountability Foundation released its new brief today on legislative measures that States can take to realise access to medicines for all. The focus...

2022 Year in Review: Highlights from the Pharmaceutical Accountability Foundation

Farma ter Verantwoording (The Pharmaceutical Accountability Foundation, PAF) had a busy 2022, with several important steps forward in its mission to further affordable access to...

What is still needed to ensure the realisation of the human right to health?

The practical meaning of the human right to the highest attainable standard of health has evolved since its first articulation in the Constitution of the...

PAF welcomes the news that the Spanish competition authority has fined Leadiant €10,25 million

AMSTERDAM: The Pharmaceutical Accountability Foundation (PAF), a group of legal and medical experts and public health advocates, today welcomes the news that the Spanish competition...

Recent Tweets

It was “an absolute disaster” that big pharma didn’t share Covid vaccines equitably with the global south.

Around 1.3 million people have died *unnecessarily* as a result, one every 24 seconds in 2021.

@NickDearden75 on the 3rd anniversary of the pandemic.


Load More